CHNC Ventures Into Latin American Country for Extension of Its Clinical Research Facilities
HOUSTON, TX, Oct. 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) announces the expansion of its clinical research services to Latin America with a new agreement/alliance with QUIASMO, an IPS medical clinic based in Bogotá, Colombia.
The ESG News Editorial Team is comprised of veteran financial journalists and sustainability analysts dedicated to providing real-time, objective reporting on global ESG regulations, climate finance, and corporate governance. Our desk monitors daily developments from the SEC, IFRS, CSRD and international regulatory bodies to ensure our 1M+ readers receive accurate, data-driven insights into the evolving sustainable investment landscape. Follow the ESG News Editorial Team for expert reporting on global sustainability standards, ESG disclosures, and climate policy. Access over 10,000 investigative reports and real-time updates.
